Phibro Animal Health (PAHC) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PAHC Annual Cash Flow →
From Phibro Animal Health through Sep 30 2025, changes in Sep 30 2026's operating cash flow provide insight into underlying business performance trends.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2026)
3 Months
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Operating Activities
Income29.52
Depreciation & amortization13.58
Amortization of Other Assets2.35
Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories33.90
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.80
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), Unrealized-0.78
Amortization Of Imputed Interest And Debt Discount-
Business Combination Acquisition Related Costs-
Pension Expense Reversal Of Expense Noncash-
Acquisition Related Items1.96
Income taxes0.00
Gain on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable-16.20
Increase (Decrease) in Accounts Payable12.27
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-25.61
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-8.35
Other Working Capital0.11
Other Noncash Income (Expense)0.76
Other net0.00
Payments for (Proceeds from) Other Operating Activities-16.26
Discontinued operations0.00
Net Cash flow from Operating Activities26.08
Investing Activities
Capital Expenditures-18.78
Sale of Capital Items0.00
Short-term Investments Proceeds13.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Capital Expenditures Incurred But Not Yet Paid-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale of Investment Projects0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities-0.17
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-5.95
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings149.00
Long-term debt - repayments-147.26
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-2.51
Proceed From Issuance Of Acquisition Note Payable Classified As Financing Activity-
Repayments Of Revolving Credit Facility-
Proceeds From Long Term Debt-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid-4.87
Net Cash Flow from Financing Activities-5.63
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow7.30
Total Cash Flow14.13
4 historic quarters locked

Sign in to unlock the full Phibro Animal Health cash flow history.

About Phibro Animal Health Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-122692

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Get the full CSIMarket dataset: Subscribe API Connect Your AI